GPhA names Ralph Neas president and CEO
This article was originally published in SRA
Executive Summary
The Generic Pharmaceutical Association has named Ralph Neas president and CEO, effective 12 September 2011. Mr Neas most recently served as president and CEO of the US National Coalition on Health Care. While at the NCHC, he enlisted the support of diverse stakeholders to forge an ad hoc Alliance on Cost Containment. Mr Neas indicated that the GPhA would be working closely with the NCHC’s cost containment alliance.
You may also be interested in...
Almirall launches Constella in six European markets
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira raises $35m in series B
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis ups public offering to $240m
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.